ÂÜÀòÂÒÂ×

Odette Becheau has a diverse work experience in the biotechnology and pharmaceutical industries. Odette currently holds the position of Senior Application Scientist at TreeFrog Therapeutics, where they play a crucial role in the deployment of Treefrog's C-Stem platform for the production of iPSCs-derived cell therapies. Their responsibilities include coordinating partner projects, acting as a scientific liaison between collaborators and internal teams, and providing market intelligence. Odette is involved in the development of various cell therapies, such as neural microtissues, cardiomyocytes, HSCs, and CAR cells.

Prior to their current role, Odette worked at Pall Corporation, starting as a Junior Bioprocess Engineer and progressing to the position of Principal Scientist. In their time at Pall, they focused on bioprocess development and scale-up projects, with a particular emphasis on cell culture processes within Single Use bioreactors. Odette also served as a Senior Bioprocess Application Specialist and Bioprocess Application Specialist.

Before Pall Corporation, Odette worked at Avertim as a Project Analyst - QA Validation at GSK Vaccines. In this role, they provided consultancy services in Quality Assurance Validation for a manufacturing production unit at GSK. Their responsibilities included writing risk assessments, validation plans, and validation strategies, as well as overseeing qualification activities.

Odette also gained experience as an Intern in molecular biology and cell culture at GSK and as a researcher at Leiden University, where they focused on E. coli protein expression and characterization.

Overall, Odette Becheau's work experience showcases their expertise in bioprocess development, cell culture, quality assurance validation, and scientific research.

Odette Becheau completed their Preparatory High School education at Lycée Pierre de Fermat in Toulouse from 2009 to 2011. In this program, they studied a range of subjects including Biology, Earth Sciences, Mathematics, Physics, Chemistry, and English. Following that, they pursued Bachelor and Master's degrees in Engineering Science with a specialization in Biotechnology at ENSTBB (Bordeaux Engineering School of Biomolecular Technology) from 2010 to 2014.